ARTICLE | Company News
Rockefeller University other research news
January 3, 2005 8:00 AM UTC
Researchers published in Nature that inhibiting the phosphorylation of Foxa2 might be an effective treatment for Type II diabetes. Foxa2 transcription is inhibited in normal mice, but in a fasted low ...